Delivery Share Breakouts : Vasudhagama Enterprises , Parmax Pharma and Others: 12-Jul-2024

Vasudhagama Enterprises Limited

The financial snapshot for Vasudhagama Enterprises Limited reveals a noteworthy performance this quarter. Net sales amounted to ₹100.69 million and total income was ₹100.69 million. The company's expenditure was ₹-88.90 million, leading to a net profit of ₹8.84 million. Earnings per Share (EPS) for continuing operations were ₹0.52. The report also highlights other income of ₹0.00 million, finance costs of ₹0.00 million, and employee benefit expenses of ₹-1.05 million. Depreciation and amortization costs were ₹-0.97 million, while current and deferred taxes were ₹-2.86 million and ₹-0.08 million, respectively. The total comprehensive income for the period stood at ₹8.84 million, with other comprehensive income net of taxes at ₹0.00 million.

The company has a market capitalization of ₹25.8 crore and a current stock price of ₹15.0. Historically, the stock has fluctuated between ₹37.9 / 8.76. With a Price-to-Earnings (P/E) ratio of 10.6, the stock appears highly valued. The book value per share is ₹24.6, and the dividend yield is 0.00%. The Return on Capital Employed (ROCE) is % and the Return on Equity (ROE) is %. The debt-to-equity ratio is very low at 0.03, although the company reports a net cash flow of ₹ crore. The Piotroski score is 1.00, and the Graham Number estimates the intrinsic value of the stock at ₹28.0. The Price-to-Book (P/B) ratio is 0.61, indicating the stock is trading at a premium relative to its book value.

Parmax Pharma Limited

For Parmax Pharma Limited, the latest financial data showcases impressive results. The company reported net sales of ₹0.00 million and total income of ₹78.24 million for the quarter. Expenditure was ₹-78.12 million, resulting in a net profit of ₹0.12 million. EPS for continuing operations was ₹0.03. Additional financial details include other income of ₹0.08 million, finance costs of ₹-1.13 million, and employee benefit expenses of ₹-7.49 million. Depreciation and amortization expenses were ₹-3.96 million. Current tax was ₹0.00 million and deferred tax amounted to ₹0.00 million. Total comprehensive income for the period was ₹0.00 million, with other comprehensive income net of taxes at ₹0.00 million.

Currently valued at ₹15.7 crore, the company's stock price is ₹42.0. It has seen a price range of ₹43.9 / 24.2 over time. The stock's Price-to-Earnings (P/E) ratio is notably high at , implying a strong valuation. The book value per share is ₹0.27 and the dividend yield is 0.00%. ROCE is recorded at -58.4%, and ROE stands at -193%. The company maintains a very low debt-to-equity ratio of 53.7, though it has a negative net cash flow of ₹-0.36 crore. The Piotroski score of 2.00 and the Graham Number of ₹ suggest some caution, while the Price-to-Book (P/B) ratio of 157 reflects a premium valuation.

KANUNGO FINANCIERS LIMITED

The latest financial figures for KANUNGO FINANCIERS LIMITED indicate a strong performance. The company achieved net sales of ₹0.00 million and total income of ₹3.40 million for the quarter. Expenditure was ₹-2.79 million, resulting in a net profit of ₹0.46 million. Earnings per Share (EPS) for continuing operations stood at ₹0.10. The report also shows other income of ₹3.40 million, finance costs of ₹-2.25 million, and employee benefit expenses of ₹-0.11 million. Depreciation and amortization expenses totaled ₹0.00 million. Current tax expense was ₹-0.15 million and deferred tax expense was ₹0.00 million. Total comprehensive income for the period was ₹0.00 million, with other comprehensive income net of taxes at ₹0.00 million.

With a market capitalization of ₹3.18 crore, the company’s stock is currently priced at ₹6.85. The historical trading range of the stock is ₹8.26 / 3.56. The P/E ratio is remarkably high at 12.2, suggesting a significant valuation. The book value stands at ₹13.0, and the dividend yield is 0.00%. The Return on Capital Employed (ROCE) is 6.24%, and the Return on Equity (ROE) is 4.41%. The debt-to-equity ratio is very low at 2.08, though the company shows a negative net cash flow of ₹-0.02 crore. The Piotroski score is 2.00, with the Graham Number pegged at ₹12.8. The Price-to-Book (P/B) ratio of 0.53 highlights a premium valuation.

Northern Spirits Limited

In the most recent financial analysis for Northern Spirits Limited, key metrics demonstrate a solid performance. The net sales reached ₹0.00 million, with total income amounting to ₹6.00 million. Expenditure was recorded at ₹-6.00 million, resulting in a net profit of ₹97.37 million. EPS figures for continuing operations are ₹6.07. Other notable figures include other income of ₹5.94 million, finance costs of ₹-39.29 million, and employee benefit expenses totaling ₹-24.70 million. Depreciation and amortization expenses were ₹-1.38 million, with current tax at ₹-35.79 million and deferred tax at ₹0.16 million. The total comprehensive income for the period was ₹0.00 million, and other comprehensive income net of taxes was ₹0.00 million.

With a market capitalization of ₹461 crore, the company’s stock is currently priced at ₹287. The historical trading range of the stock is ₹576 / 0.00. The P/E ratio is remarkably high at 27.8, suggesting a significant valuation. The book value stands at ₹62.3, and the dividend yield is 0.00%. The Return on Capital Employed (ROCE) is 17.6%, and the Return on Equity (ROE) is 19.9%. The debt-to-equity ratio is very low at 1.38, though the company shows a negative net cash flow of ₹9.69 crore. The Piotroski score is 5.00, with the Graham Number pegged at ₹120. The Price-to-Book (P/B) ratio of 4.61 highlights a premium valuation.